Clinical trial
Neuromodulation of Lidocaine Cream Effect on Chronic Pain Patients
NCT03046017 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuromodulation of Lidocaine Cream Effect on Chronic Pain Patients
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 30, 2017
- Completion date
- May 31, 2023
- Enrollment
- 90 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic low back pain